Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
09/05China's CNBG, Sinovac find more countries to test coronavirus vaccines
RE
09/05SANOFI FRANCE CHIEF : future COVID-19 vaccine seen below 10 euros
RE
09/04BLUEPRINT MEDICINES : Roche, Blueprint lung cancer drug wins FDA approval
RE
09/04BeiGene Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs
DJ
09/04ROCHE : Gets FDA Emergency Authorization for Test for Covid-19, Flu
DJ
09/04Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan
RE
09/04ROCHE : receives U.S. emergency approval for coronavirus vs. flu test
RE
09/04ROCHE HOLDINGS AG : JP Morgan reiterates its Buy rating
MD
09/03Pfizer sees COVID-19 vaccine data in thick of U.S. election fight
RE
09/03GILEAD SCIENCES : Kite Forms AML Collaboration With HiFiBiO Therapeutics
DJ
09/03PHILIPS NV : JP Morgan reiterates its Neutral rating
MD
09/03GERRESHEIMER AG : JP Morgan remains Neutral
MD
09/03FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan gives a Buy rating
MD
09/03FRESENIUS SE : JP Morgan gives a Buy rating
MD
09/03Sanofi, GSK launch trial for COVID-19 protein-based vaccine
RE
Discover
09/03BAYER AG : Credit Suisse gives a Neutral rating
MD
09/03SANOFI : GlaxoSmithKline Start Phase 1/2 Trial of Covid-19 Vaccine Candidate
DJ
09/03Sanofi, GSK launch trial for COVID-19 protein-based vaccine
RE
09/03ROCHE : presents new data on efficacy of MS treatment Ocrevus
RE
09/02U.S. CDC tells states to prep for COVID-19 vaccine distribution as soon as late October
RE
09/02U.S. CDC tells states to prep for COVID-19 vaccine distribution by Nov
RE
09/02Correction to the Vaccine Article
DJ
09/02ASTRAZENECA COVID-19 VACCINE COULD BE ON THE MARKET BY END OF 2020 : Italy minister
RE
09/02BAYER : LifeLabs, Bayer Inc. to Offer Complimentary Test to Detect TRK Fusion Cancer
DJ
09/02SONIC HEALTHCARE : U.S. NIH awards nine companies $129 mln to scale up COVID-19 testing
RE
09/02J&J's Janssen to End Pimodivir Influenza Development Program
DJ
09/02STRYKER : UK CMA Seeks Comments About Stryker, Wright Medical Offer Before Making Ruling
DJ
09/02ROCHE HOLDINGS AG : UBS reiterates its Buy rating
MD
09/02ROCHE HOLDINGS AG : Receives a Buy rating from JP Morgan
MD
09/02CARL ZEISS MEDITEC AG : From Neutral to Buy by Hauck & Aufhauser
MD
09/01BAYER : appeals $20.5 million Roundup ruling to California Supreme Court
RE
09/01BAYER : appeals $20.5 mln Roundup ruling to California Supreme Court
RE
09/01BRISTOL MYERS SQUIBB : Gets FDA Approval for Onureg Tablets
DJ
09/01HUMANA : Boosts Full Year EPS Guidance
DJ
09/01JOUNCE THERAPEUTICS : Shares Up 54% After License Agreement With Gilead
DJ
09/01VERTEX PHARMACEUTICALS : Says FDA to Review Applications for Expanded Use of Trikafta, Symdeko, Kalydeco
DJ
09/01GILEAD SCIENCES : Jounce In License Agreement for Immunotherapy Program
DJ
09/01BAYER AG : UBS gives a Buy rating
MD
09/01NOVARTIS AG : Raised to Buy by Morgan Stanley
MD
09/01FRESENIUS SE : Morgan Stanley reaffirms its Buy rating
MD
09/01GLAXOSMITHKLINE : Morgan Stanley maintains a Sell rating
MD
09/01PHILIPS NV : Deutsche Bank reaffirms its Buy rating
MD
09/01PHILIPS NV : UBS reiterates its Buy rating
MD
09/01Thanks for the COVID vaccine, but can you say that in Estonian?
RE
09/01ASTRAZENECA : bolsters COVID-19 vaccine supply with new deal
RE
09/01ASTRAZENECA : bolsters COVID-19 vaccine supply with new deal
RE
09/01SHIONOGI : Japan to participate in WHO coronavirus vaccine programme
RE
09/01ASTRAZENECA : Imfinzi wins EU approval for aggressive form of lung cancer
RE
09/01ASTRAZENECA : Oxford Biomedica expand COVID-19 vaccine supply tie-up
RE
09/01ASTRAZENECA : Imfinzi Gets EU Approval for Small Cell Lung Cancer
DJ
09/01ASTRAZENECA : Kidney-Disease Drug Shows Positive Effects in Phase 3 Trial
DJ
09/01Roche gets U.S. approval for HIV testing equipment
RE
09/01REGENERON PHARMACEUTICALS : Sanofi says Kevzara drug fails as possible COVID-19 treatment
RE
09/01SANOFI : Kevzara Phase 3 Trial for Covid-19 Failed to Meet Primary Endpoint
DJ
09/01NOVARTIS : sets out new sustainability targets on patient outreach, carbon neutrality
RE
08/31Asian stocks edge up after strong China manufacturing survey
RE
08/31AstraZeneca's COVID-19 vaccine candidate begins late-stage U.S. study
RE
08/31Australia shares hit four-week low ahead of cenbank decision
RE
08/31AstraZeneca's COVID-19 vaccine candidate begins late-stage U.S. study
RE
08/31ASTRAZENECA : Covid-19 Vaccine Candidate Expanding Into U..S. Phase III Trial
DJ
08/31CABEI approves $400 mln loan to Central American nations for vaccine
RE
08/31Canada wants to be at 'front of line' for coronavirus vaccines, signs deals with Novavax and Johnson & Johnson
RE
08/31Nestle gets peanut allergy treatment with $2 billion Aimmune buyout
RE
08/31Nestle gets peanut allergy treatment with $2 billion Aimmune buyout
RE
08/31S&P 500 on track for best August since 1984
RE
Discover
08/31BAXTER INTERNATIONAL : Says FDA Grants De Novo Application for Theranova Dialysis Membrane
DJ
08/31KONINKLIJKE PHILIPS N : U.S. scraps Philips ventilator order in 2020 earnings blow
RE
08/31DAIICHI SANKYO : COVID-19 vaccine selected by Japanese drug discovery body
RE
08/31KONINKLIJKE PHILIPS N : Philips Cuts 2020 Outlook After Ventilator Contract With US Health Department Cancelled
DJ
08/31KONINKLIJKE PHILIPS N : U.S. scraps Philips ventilator order in 2020 earnings blow
RE
Prev.1  2  3  4   5  6  7  8  9  10Next